The changing face of hospitalisation due to gastrointestinal bleeding and perforation

Alimentary Pharmacology and Therapeutics

Volumn 33, Issue 5, 2011, Pages 585-591

  Lanas, A ^a,b,c   Garcia Rodriguez L A ^d   Polo Tomas M ^b   Ponce, M ^b,e   Quintero, E ^f   Perez Aisa, M A ^g   Gisbert, J P ^b,h   Bujanda, L ^b,i   Castro, M ^b,j   Munoz M ^k   Del Pino, M D ^l   Garcia, S ^m   Calvet, X ^b,n  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^d Department of Pharmacoepidemiology   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^g HOSPITAL COSTA DEL SOL   (Spain)

^h HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

ⁱ UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^j HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^k Hospital de Asturias   (Spain)

^l HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^m HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

ⁿ HOSPITAL DE SABADELL   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANGIODYSPLASIA; ARTICLE; COLON DIVERTICULOSIS; DIGESTIVE SYSTEM PERFORATION; DISEASE SEVERITY; DRUG USE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; HUMAN; INCIDENCE; INTESTINE PERFORATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER BLEEDING; POPULATION RESEARCH; PRIORITY JOURNAL; SPAIN; ULCER PERFORATION;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; HUMANS; INTESTINAL PERFORATION; MALE; MIDDLE AGED; SPAIN;

EID: 79251532089     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04563.x     Document Type: Article

References (23)

1. Sung JJ, Kuipers EJ, El-serag HB,. Systematic review. The global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther 2009; 29: 938-46.
2. Sonnenberg A,. Time trends of ulcer mortality in Europe. Gastroenterology 2007; 132: 2320-7.
3. Post PN, Kuipers EJ, Meijer GA,. Declining incidence of peptic ulcer but not of its complications: a nation-wide study in The Netherland. Aliment Pharmacol Ther 2006; 23: 1587-93.
4. Ohmann C, Imhof M, Ruppert C, et al. Time-trends in the epidemiology of peptic ulcer bleeding. Scand J Gastroenterol 2005; 40: 914-20.
5. Kang JY, Elders A, Majeed A, Maxwell JD, Bardhan KD,. Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002. Aliment Pharmacol Ther 2006; 24: 65-79.
6. Paimela H, Paimela L, Myllykangas-Luosujarvi R, Kivilaakso E,. Current features of peptic ulcer disease in Finland: incidenceof surgery, hospital admissions and mortality for the disease during the past twenty-five years. Scand J Gastroenterol 2002; 37: 399-403.
7. Lanas A, García-Rodríguez LA, Polo-Tomás M, et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 2009; 104: 1633-41.
8. Zhao Y, Encinosa W,. Hospitalizations for Gastrointestinal Bleeding in 1998 and 2006. HCUP Statistical Brief #65. Rockville, MD: Agency for Healthcare Research and Quality, 2008. Available at:.
9. Bardhan KD, Royston C,. Time, change and peptic ulcer disease in Rotherham, UK. Dig Liver Dis 2008; 40: 540-6.
10. Paimela H, Oksala NK, Kivilaakso E,. Surgery for peptic ulcer today. A study on the incidence, methods and mortality in surgery for peptic ulcer in Finland between 1987 and 1999. Dig Surg 2004; 21: 185-91.
11. Lanas A, Perez-Aisa MA, Feu F, et al. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol 2005; 100: 1685-93.
12. Raiford DS, Pérez Gutthann S, García Rodríguez LA,. Positive predictive value of ICD-9 codes in the identification of cases of complicated peptic ulcer disease in the Saskatchewan hospital automated database. Epidemiology 1996; 7: 101-4.
13. Harris S,. Medicare severity-refined DRGs: an improved system. Available at:.
14. Sadic J, Borgström A, Manjer J, Toth E, Lindell G,. Bleeding peptic ulcer-time trends in incidence, treatment and mortality in Sweden. Aliment Pharmacol Ther 2009; 30: 392-8.
15. Hermansson M, Ekedahl A, Ranstam J, Zilling T,. Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002. BMC Gastroenterol 2009; 9: 25.
16. Bak Andersen I, Bonnevie O, Jorgensen T, Sorensen T,. Time trends for peptic ulcer disease in Denmark, 1981-1993. Analysis of hospitalization register and mortalitydata. Scand J Gastroenterol 1998; 33: 260-6.
17. Pérez-Aisa MA, Del Pino D, Siles M, Lanas A,. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther 2005; 21: 65-72.
18. Lanas A, Esplugues JV, Zapardiel J, Sobreviela E,. Education-based approach to addressing non-evidence-based practice in preventing NSAID-associated gastrointestinal complications. World J Gastroenterol 2009; 15: 5953-9.
19. Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL,. Underutilization of preventive strategies in patients receiving NSAIDs. Rheumatology (Oxford) 2003; 42 (Suppl. 3): iii23-31.
20. Barkun AN, Martel M, Toubouti Y, Rahme E, Bardou M,. Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses. Gastrointest Endosc 2009; 69: 786-99.
21. Bardhan KD, Williamson M, Royston C, Lyon C,. Admission rates for peptic ulcer in the trent region, UK, 1972-2000. changing pattern, a changing disease? Dig Liver Dis 2004; 36: 577-88.
22. Lanas A, García-Rodríguez LA, Arroyo MT, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal -inflammatory drugs, aspirin and combinations. Gut 2006; 55: 1731-8.
23. Humes DJ, Solaymani-Dodaran M, Fleming KM, Simpson J, Spiller RC, West J,. A population-based study of perforated diverticular disease incidence and associated mortality. Gastroenterology 2009; 136: 1198-205.